{"organizations": [], "uuid": "8563170912ee3a2bb8235b96c7b1d711bc9aefaa", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-synergy-pharmaceuticals-qtrly-loss/brief-synergy-pharmaceuticals-qtrly-loss-per-share-0-16-idUSASB0C8HY", "country": "US", "domain_rank": 408, "title": "BRIEF-Synergy Pharmaceuticals Qtrly Loss Per Share ‍$0.16", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-01T23:59:00.000+02:00", "replies_count": 0, "uuid": "8563170912ee3a2bb8235b96c7b1d711bc9aefaa"}, "author": "", "url": "https://www.reuters.com/article/brief-synergy-pharmaceuticals-qtrly-loss/brief-synergy-pharmaceuticals-qtrly-loss-per-share-0-16-idUSASB0C8HY", "ord_in_thread": 0, "title": "BRIEF-Synergy Pharmaceuticals Qtrly Loss Per Share ‍$0.16", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "March 1 (Reuters) - Synergy Pharmaceuticals Inc:\n* SYNERGY PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE\n* QTRLY LOSS PER SHARE ‍$0.16 * Q4 EARNINGS PER SHARE VIEW $-0.19 — THOMSON REUTERS I/B/E/S Source text for Eikon:\n ", "external_links": [], "published": "2018-03-01T23:59:00.000+02:00", "crawled": "2018-03-02T00:12:26.000+02:00", "highlightTitle": ""}